However, as subcutaneous MLL tumours did not stimulate AT1 tumour growth in the same manner as MLL tumours grown in the prostate, it appears that MLL‐induced changes in the local prostate microenvironment are more important for intraprostatic AT1 tumour growth than systemic instigation. The gene discussed is KMT2A; the disease is neoplasm.